Claims
- 1. A process for preparing in high yield the enantiomerically-pure 3-methyl-5-(1-(C.sub.1 -C.sub.3 -alkyl)-2-pyrrolidinyl)isoxazole of the formula ##STR28## wherein Alk is C.sub.1 -C.sub.3 -alkyl, comprising: (a) reacting a starting material, (S)-pyroglutamic acid, having the formula ##STR29## with an esterifying reagent at from -10.degree. C. to 80.degree. C. for from 3-to-48 hours, to prepare the (S)-pyroglutamic acid ester having the formula, ##STR30## wherein R.sup.1 is methyl or ethyl; (b) reacting the (S)-pyroglutamic acid ester with an excess of a salt of the dianion of acetone oxime in a suitable solvent, at a temperature of from -30.degree. C. to ambient temperature, with vigorous mixing of the reagents, to form the intermediate product, 1-(1-methyl-5-oxo-2(S)-pyrrolidinyl)-1,3-butanedione-3-oxime, which is not isolated, but which is dehydrated and cyclized by reaction with a strong acid at ambient-to-reflux temperature for from 0.5-to-3 hours, to produce the novel 5(S)-(3-methyl-5-isoxazolyl)-2-pyrrolidinone compound having the formula ##STR31## (c) reducing the 5(S)-(3-methyl-5-isoxazolyl)-2-pyrrolidinone with a reducing agent known to reduce lactams to cyclic amines, particularly an agent selected from the group consisting of lithium aluminum hydride, NaBH.sub.4 /BF.sub.3, NaBH.sub.4 /CH.sub.3 SO.sub.3 H, NaBH.sub.4 /camphorsulfonic acid, borane/dimethyl sulfide and borane/THF, to give the 3-methyl-5-(2(S)-pyrrolidinyl)isoxazole compound having the formula ##STR32## then (d) N-alkylating the 3-methyl-5-(2(S)-pyrrolidinyl)isoxazole by treatment with an N-alkylating agent, such as formaldehyde, acetaldehyde or propanal, for example, in the presence of a reducing agent and under reaction conditions capable of reducing an iminium compound, and isolating the desired 3-methyl-5-(1-(C.sub.1 -C.sub.3 -alkyl)-2-pyrrolidinyl)isoxazole in high chiral purity.
- 2. The process according to claim 1, wherein Alk is methyl and wherein in step (a), the esterifying reagent is methanol in the presence of a strong acid; in step (c), the intermediate product is not isolated; and in step (d), the N-alkylating agent is formaldehyde in the presence of formic acid at ambient or an elevated temperature.
- 3. The process according to claim 1, wherein R.sup.1 is methyl and wherein in step (a), the esterifying reagent is methanol and sulfuric acid; in step (b) the (S)-pyroglutamic acid ester compound is reacted with 2.0 equivalents of the lithium salt of the dianion of acetone oxime in a solution of THF:hexane, wherein the ratio of THF:hexane is 3:2, and the dehydrating and cyclizing reagent is concentrated sulfuric acid; and in step (c) reducing the 5(S)-(3-methyl-5-isoxazolyl)-2-pyrrolidinone compound with borane in THF.
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a divisional of application Ser. No. 08/475,717 filed Jun. 7, 1995, now U.S. Pat. No. 5,516,912 which is a continuation-in-part of application Ser. No. 08/234,442 filed Apr. 28, 1994, now U.S. Pat. No. 5,424,444 which is a continuation-in-part of application Ser. No. 08/117,819, filed Sep. 8, 1993, now abandoned.
US Referenced Citations (1)
Number |
Name |
Date |
Kind |
5409946 |
Garvey et al. |
Apr 1995 |
|
Non-Patent Literature Citations (2)
Entry |
CA 123:9432 Method of . . . isoxazoles. Lin et al., 1994. |
CA 123:55872 Isoxazole, . . . function. Garvey et al., (1967). |
Divisions (1)
|
Number |
Date |
Country |
Parent |
475717 |
Jun 1995 |
|
Continuation in Parts (2)
|
Number |
Date |
Country |
Parent |
234442 |
Apr 1994 |
|
Parent |
117819 |
Sep 1993 |
|